AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies.
Omlin, A Jones, R van der Noll, R Satoh, T Niwakawa, M Smith, S A Graham, J Ong, M Finkelman, R Schellens, J
Omlin, A
Jones, R
van der Noll, R
Satoh, T
Niwakawa, M
Smith, S A
Graham, J
Ong, M
Finkelman, R
Schellens, J
Citations
Altmetric:
Abstract
AZD3514 is a first-in-class, orally bio-available, androgen-dependent and -independent androgen receptor inhibitor and selective androgen-receptor down-regulator (SARD).
Authors
Description
Date
2015-06
Publisher
Collections
Keywords
Type
Article
Citation
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies. 2015, 33 (3):679-90 Invest New Drugs